sábado, 29 de febrero de 2020

FDA approves a generic version of the drug Martin Shkreli monopolized

FDA approves a generic version of the drug Martin Shkreli monopolized

Daily Recap

FDA approves a generic version of the drug Martin Shkreli monopolized

By DAMIAN GARDE


DREW ANGERER/GETTY IMAGES
The approval means Shkreli's company, once called Turing and now known as Phoenixus, will no longer have a monopoly on Daraprim.

No hay comentarios:

Publicar un comentario